Owing to the lack of correlation between plaque burden and cognitive impairment, as well as a growing understanding of the toxicity of fibrillar and pre-fibrillar intermediate species of Aβ and tau, the hypothesis has been revised to include roles for Aβ oligomers and tau oligomers [27]. This evidence concerns the gene MAPT and Cognitive impairment.